Brief for American Medical Association, American Society of Human Genetics, American College of Obstetricians and Gynecologists, American College of Embryology, and the Medical Society of the State of New York as Amici Curiae in Support of Plaintiffs-Appellees and Arguing for Affirmance, Association for Molecular Pathology v. U.S. Patent and Trademark Office, 689 F.3d 1303 (Fed. Cir. 2012) (No. 2010–1406).
45 Pages Posted: 8 Dec 2017
Date Written: December 6, 2010
Abstract
This is the brief for the AMA and other medical associations in the Federal Circuit authored by Lori Andrews and Josh Sarnoff. It addresses the ineligibility for patents of isolated discovered and claimed DNA sequences and cDNA, and the adverse consequences of granting such patents.
Keywords: patent, isolated DNA, cDNA, medicine, medical care, subject matter eligiblity
JEL Classification: K11, K20, K21, K30, N00, H41, O30, O31, O34, O38
Suggested Citation: Suggested Citation
Sarnoff, Joshua D. and Andrews, Lori, Brief for American Medical Association, American Society of Human Genetics, American College of Obstetricians and Gynecologists, American College of Embryology, and the Medical Society of the State of New York as Amici Curiae in Support of Plaintiffs-Appellees and Arguing for Affirmance, Association for Molecular Pathology v. U.S. Patent and Trademark Office, 689 F.3d 1303 (Fed. Cir. 2012) (No. 2010–1406). (December 6, 2010). Available at SSRN: https://ssrn.com/abstract=2276528 or http://dx.doi.org/10.2139/ssrn.2276528
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.